1. Home
  2. PHGE vs GV Comparison

PHGE vs GV Comparison

Compare PHGE & GV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHGE
  • GV
  • Stock Information
  • Founded
  • PHGE 2015
  • GV 2013
  • Country
  • PHGE Israel
  • GV Canada
  • Employees
  • PHGE N/A
  • GV N/A
  • Industry
  • PHGE Biotechnology: Pharmaceutical Preparations
  • GV Other Consumer Services
  • Sector
  • PHGE Health Care
  • GV Real Estate
  • Exchange
  • PHGE Nasdaq
  • GV Nasdaq
  • Market Cap
  • PHGE 13.3M
  • GV 12.3M
  • IPO Year
  • PHGE N/A
  • GV 2022
  • Fundamental
  • Price
  • PHGE $0.63
  • GV $3.10
  • Analyst Decision
  • PHGE Strong Buy
  • GV
  • Analyst Count
  • PHGE 2
  • GV 0
  • Target Price
  • PHGE $23.00
  • GV N/A
  • AVG Volume (30 Days)
  • PHGE 117.4K
  • GV 14.0M
  • Earning Date
  • PHGE 05-19-2025
  • GV 04-08-2025
  • Dividend Yield
  • PHGE N/A
  • GV N/A
  • EPS Growth
  • PHGE N/A
  • GV N/A
  • EPS
  • PHGE N/A
  • GV 0.32
  • Revenue
  • PHGE N/A
  • GV $9,380,985.00
  • Revenue This Year
  • PHGE N/A
  • GV N/A
  • Revenue Next Year
  • PHGE N/A
  • GV N/A
  • P/E Ratio
  • PHGE N/A
  • GV $10.01
  • Revenue Growth
  • PHGE N/A
  • GV 11.25
  • 52 Week Low
  • PHGE $0.48
  • GV $1.00
  • 52 Week High
  • PHGE $4.99
  • GV $9.60
  • Technical
  • Relative Strength Index (RSI)
  • PHGE 49.87
  • GV 43.30
  • Support Level
  • PHGE $0.48
  • GV $3.00
  • Resistance Level
  • PHGE $0.58
  • GV $3.38
  • Average True Range (ATR)
  • PHGE 0.06
  • GV 0.74
  • MACD
  • PHGE 0.00
  • GV -0.35
  • Stochastic Oscillator
  • PHGE 68.16
  • GV 1.87

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.

About GV Visionary Education Technology Holdings Group Inc.

Visionary Holdings Inc is a private education providing company located in Canada, with subsidiaries in Canada and market partners in China, that offers high-quality education resources to students around the globe. The company aims to provide access to secondary, college, undergraduate and graduate, and vocational education to students in Canada through technological innovation so that more people can learn, grow, and succeed to their full potential. As a fully integrated provider of educational programs and services in Canada, the company has been serving and will continue to serve both Canadian and international students.

Share on Social Networks: